Hydromer, Inc. has announced its expansion into manufacturing and supplying UV coating, curing and testing equipment, building on over 40 years of experience in hydrophilic, thromboresistant and antimicrobial coating technologies. This strategic move allows the company to provide medical device manufacturers with a comprehensive solution that integrates proprietary coatings with high-performance application machinery. The integrated platform enables manufacturers to correlate process parameters directly with performance outcomes, supporting compliance with ISO 13485 and FDA Quality System Regulations (21 CFR Part 820). According to Michael Torti, CEO of Hydromer, this expansion eliminates technical barriers and helps clients reduce time to market while maintaining high quality standards and regulatory confidence.
The company's expanded equipment platform includes several key systems. The Hydrophilic Coating Equipment delivers uniform coating application and UV curing with minimal manual intervention. The Automated High-Throughput Coating System features a modular design with load, dip coating and UV curing workstations that can be operated by a single operator to increase production rates and reduce reliance on manual labor. Additionally, Friction Testing Equipment provides precise and repeatable measurements for lubricity tests to support performance evaluation and quality control. This expansion represents a significant development in the medical device manufacturing sector, where consistent coating application and regulatory compliance are critical.
By controlling both the coating formulations and the application equipment, Hydromer aims to provide manufacturers with greater process control and reliability. The company's approach addresses the growing demand for automated solutions in medical device production, particularly as manufacturers seek to improve efficiency while meeting stringent regulatory requirements. The original announcement can be viewed on New Media Wire, where the company detailed its expansion plans. This strategic move positions Hydromer to serve medical device manufacturers more comprehensively, offering both the coating technologies and the equipment needed for their application. The integration of coatings and equipment is expected to streamline manufacturing processes and enhance quality control for medical device companies operating in global markets.
The importance of this expansion lies in its potential to transform medical device manufacturing by providing integrated solutions that address both technical and regulatory challenges. Medical device manufacturers face increasing pressure to accelerate product development while maintaining rigorous quality standards and compliance with evolving regulations. Hydromer's combined offering of proprietary coatings and specialized application equipment creates a closed-loop system where manufacturers can optimize both material performance and process parameters simultaneously. This integrated approach reduces variability in coating application, which is crucial for medical devices where surface properties directly impact safety and functionality.
The equipment platform's design specifically addresses pain points in medical device manufacturing, including the need for consistent coating thickness, reliable curing processes, and quantifiable performance metrics. The Automated High-Throughput Coating System's modular architecture allows manufacturers to scale production according to demand while maintaining process consistency. The inclusion of Friction Testing Equipment provides manufacturers with objective data to validate coating performance, supporting both quality control processes and regulatory submissions. This comprehensive solution becomes particularly valuable as medical device companies navigate complex global markets with varying regulatory requirements, where documentation of process control and performance validation is essential for market access and commercial success.
